Cesar A. Virgen

Dermatology
1275 York Ave
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders.

JAK2 Fusions in Adult Patients With Mycosis Fungoides and CD30 Lymphoproliferative Disorders.

Journal: JAMA dermatology
Published: November 26, 2025

CD19 CAR T-Cell Therapy in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

CD19 CAR T-Cell Therapy in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Journal: American journal of hematology
Published: November 05, 2025

Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets.

Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets.

Journal: Haematologica
Published: October 23, 2025

Vulvar Squamous Cell Carcinoma Guidelines May Benefit From Consideration of Tissue-Sparing Techniques as Treatment Options.

Vulvar Squamous Cell Carcinoma Guidelines May Benefit From Consideration of Tissue-Sparing Techniques as Treatment Options.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2024

Alaskapox virus, an emerging Orthopoxvirus in the Arctic region.

Alaskapox virus, an emerging Orthopoxvirus in the Arctic region.

Journal: International journal of dermatology
Published: March 06, 2024

Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib.

Treatment-refractory cutaneous Rosai-Dorfman disease responsive to oral methotrexate and topical trametinib.

Journal: JAAD case reports
Published: August 31, 2023

Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease.

Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease.

Journal: JAAD case reports
Published: March 09, 2023

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma.

Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma.

Journal: The oncologist
Published: December 12, 2022

Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.

Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report.

Journal: Clinical and experimental dermatology
Published: November 03, 2022

Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience.

Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience.

Journal: Journal of the American Academy of Dermatology
Published: October 13, 2022

Vulvar squamous cell carcinoma guidelines do not include tissue-sparing techniques as a treatment option.

Vulvar squamous cell carcinoma guidelines do not include tissue-sparing techniques as a treatment option.

Journal: International journal of women's dermatology
Published: October 11, 2022

Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.

Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.

Journal: Leukemia & lymphoma
Published: July 21, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026